Dr. Elizabeth Nanak will take GlycoNet to the next phase of improving the health of Canadians through scientific knowledge and technologies built upon glycoscience.
Edmonton-based biotech 48Hour Discovery is invited to travel to Pangyo Technoo Valley, the Korean version of the Silicon Valley, to expand their technology into the Asian market.
Discovering antiviral and anticancer drugs will soon be faster and cheaper thanks to new research from GlycoNet Investigator Dr. Robert Britton at Simon Fraser University and his international team.
The partnership, funded by NSERC Alliance Grant, will support Dr. Warren Wakarchuk’s work on the role of O-glycans in triggering immune response.
Dr. Rui Resendes will develop business opportunities and build strategic partnerships to advance Network research priorities.
Funding will enable Drs. Yves St-Pierre, David Chatenet, and Nicolas Doucet to develop a revolutionary immunotherapy against breast cancer.
Founded in 2015, GlycoNet has been working to develop a collaborative national network to accelerate carbohydrate-based healthcare treatments, vaccine, and technologies for Canadians.
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.